BreakVax
Sponsors
BreakBio Corp
Conditions
Glioblastoma (GBM)Triple-Negative Breast Cancer (TNBC)
Phase 1
Combination Immunotherapy Treatment for Locally Advanced Unresectable or Metastatic, PD-L1 Negative (CPS<10), gBRCA Negative, Triple Negative Breast Cancer Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 Therapy
Not yet recruitingNCT07762703
Start: 2026-09-01End: 2030-09-01Target: 10Updated: 2026-08-19
Combination Immunotherapy Treatment for Glioblastoma Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 Therapy
Not yet recruitingNCT07762716
Start: 2026-09-01End: 2030-09-01Target: 10Updated: 2026-08-19